Geron (GERN) Other Non-Current Liabilities (2012 - 2026)
Geron's (GERN) quarterly Other Non-Current Liabilities came in at $110.4 million in Q1 2026, little changed year-on-year from $110.4 million in Q1 2025, and down 1.56% quarter-over-quarter from $112.1 million in Q4 2025.
Geron (GERN) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Geron has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $110.4 million for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $110.4 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.4 million (changed 0.0% YoY), and the FY2025 annual result was $112.1 million, up 7.39% from the prior year.
- Other Non-Current Liabilities came in at $110.4 million for Q1 2026 at Geron, down from $112.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $112.1 million in Q4 2025 to a low of $104.4 million in Q4 2024.
- The 3-year median for Other Non-Current Liabilities is $110.4 million (2025), against an average of $109.6 million.
- Across the five-year window, Other Non-Current Liabilities gained 7.39% in 2025 and climbed 0.0% in 2026, its largest moves.
- Geron's Other Non-Current Liabilities stood at $104.4 million in 2024, then grew by 7.39% to $112.1 million in 2025, then retreated by 1.56% to $110.4 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $110.4 million (Q1 2026), $112.1 million (Q4 2025), and $110.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.38 Mn |
| Dec 31, 2025 | 112.13 Mn |
| Sep 30, 2025 | 110.04 Mn |
| Jun 30, 2025 | 110.53 Mn |
| Mar 31, 2025 | 110.38 Mn |
| Dec 31, 2024 | 104.42 Mn |
| Dec 31, 2014 | 16,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 290,000.00 |
| Mar 31, 2014 | 143,000.00 |
| Dec 31, 2013 | 367,000.00 |
| Sep 30, 2013 | 258,000.00 |
| Jun 30, 2013 | 50,000.00 |
| Mar 31, 2013 | 26,000.00 |
| Dec 31, 2012 | 51,000.00 |